Assessment of the Angiogenic Potential of 2-Deoxy-D-Ribose Using a Novel in vitro 3D Dynamic Model in Comparison With Established in vitro Assays

Serkan Dıkıcı, Betül Aldemir Dikici, Shirin Issa Bhaloo, Mercedes Balcells, Elazer R. Edelman, Sheila MacNeil, Gwendolen C. Reilly, Colin Sherborne, Frederik ClaeyssensFrontiers in Bioengineering and Biotechnology 2020 · DOI

Abstract

Angiogenesis is a highly ordered physiological process critical for tissue engineering to ensure construct survival post-transplantation. This study introduces a novel 3D in vitro dynamic model to evaluate pro-angiogenic agents under physiologically relevant conditions. We compared the angiogenic potential of 2-deoxy-D-ribose (2dDR) with vascular endothelial growth factor (VEGF). Results from conventional 2D assays and the new 3D model demonstrate that 2dDR significantly promotes endothelial cell proliferation, migration, and infiltration, especially when combined with dynamic fluid flow, making it a cost-effective alternative to traditional growth factors.

Introduction

The rapid neovascularization of tissue-engineered constructs remains the "holy grail" of the field. While pro-angiogenic agents offer a solution, current testing models are often insufficient. Standard 2D in vitro assays are fast but lack structural complexity and mechanical stimuli like shear stress. Conversely, in vivo animal models are realistic but ethically complex, expensive, and time-consuming. This research addresses this gap by developing a 3D bilayer tubular model that simulates both the architecture of a blood vessel and the dynamic mechanical environment of blood flow.

Materials and Methods

The study utilized a custom-fabricated bilayer tubular scaffold to mimic the vascular environment and a 3D-printed bioreactor for dynamic testing.

Scaffold Fabrication

The scaffold consists of two distinct layers designed to simulate the vessel wall:

  1. Inner Layer: PHBV nanofibers produced via rotational electrospinning to mimic the basement membrane, providing a tight surface for Human Aortic Endothelial Cell (HAEC) attachment.
  2. Outer Layer: A highly porous PCL PolyHIPE (polymerized high internal phase emulsion) tube. Its large, interconnected pores allow cells to migrate outward from the inner layer, simulating tissue infiltration.

The layers were joined using a "shrink-fit" technique: the PolyHIPE tube was swollen in ethanol, the inner PHBV tube was inserted, and the assembly was transferred to water, causing the outer tube to shrink and create a tight mechanical bond.

Fabrication and assembly of the bilayer tubular scaffold: (A) Moulding of the PolyHIPE tube, (B) Rotational electrospinning of the PHBV tube, (C) Assembly via shrink-fitting, and (D) Photograph of the final bilayer construct.

Dynamic Bioreactor System

A custom 3D-printed bioreactor was developed to house the bilayer tubes. The system was connected to a pump to provide controlled shear stress (1, 2, or 10 dyn/cm²), simulating physiological flow conditions. The chambers are highly accessible, costing approximately $15 each to produce.

Results and Discussion

2D Comparative Assays

Initial testing using standard 2D assays confirmed that 2dDR is a potent angiogenic agent. At an optimal concentration of 100 µM, 2dDR doubled cell numbers by day 7 and increased capillary-like tube formation by 1.8-fold, achieving approximately 95% of the potency of the gold-standard VEGF (80 ng/mL). However, high concentrations (10 mM) were found to be cytotoxic, causing cell detachment.

3D Dynamic Model Performance

The 3D model revealed a significant synergistic effect between chemical stimulation (2dDR) and mechanical stimuli (flow):

  • Cell Infiltration: Under static conditions, 2dDR-treated cells migrated ~182 µm into the porous outer scaffold. Under a low flow rate of 2 dyn/cm², this infiltration distance increased dramatically to ~780 µm.
  • Cell Density: The combination of 2dDR and optimal flow resulted in a 3.8-fold increase in cell density compared to static controls.
  • Flow Sensitivity: Flow rates of 10 dyn/cm² were found to be too high, preventing stable monolayer formation by washing away cells.

Mechanistic Insights

Unlike exogenous VEGF, which acts as a direct ligand, 2dDR appears to work by inducing controlled oxidative stress. This triggers the cells to secrete their own endogenous growth factors, such as VEGF and IL-8, promoting a more natural angiogenic response.

Conclusion and Future Directions

The novel 3D dynamic model provides a cost-effective and physiologically relevant platform for testing pro-angiogenic agents. While the current study focused on a single cell type over 7 days, future iterations incorporating co-cultures and longer durations will further enhance its predictive value for in vivo success.

Summary updated

Abstract

Angiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical stimuli. One of the most important challenges in tissue engineering is the rapid neovascularization of constructs to ensure their survival after transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted approach. The study of angiogenesis has gained momentum over the last two decades. Although there are various <i>in vitro, ex vivo</i>, and <i>in vivo</i> angiogenesis models that enable testing of newly discovered pro-angiogenic agents, the problem with researching angiogenesis is the choice of the most appropriate assay. <i>In vivo</i> assays are the most representative and reliable models, but they are expensive, time-consuming and can cause ethical concerns whereas <i>in vitro</i> assays are relatively inexpensive, practical, and reproducible, but they are usually lack of enabling the study of more than one aspect of angiogenesis, and they do not fully represent the complexity of physiological angiogenesis. Therefore, there is a need for the development of an angiogenesis model that allows the study of angiogenesis under physiologically more relevant, dynamic conditions without causing ethical concerns. Accordingly, in this study, we developed 3D <i>in vitro</i> dynamic angiogenesis model, and we tested the angiogenic potential of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor (VEGF) using newly developed <i>in vitro</i> 3D dynamic model and well-established <i>in vitro</i> models. Our results obtained using conventional <i>in vitro</i> assays demonstrated that 2dDR promoted proliferation, migration and tube formation of human aortic endothelial cells (HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further assessed using the newly developed 3D <i>in vitro</i> model, which enabled the monitoring of cell proliferation and infiltration simultaneously under dynamic conditions. Our results showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth of HAECs and the cellular density under either static or dynamic conditions.
BibTeX
@inproceedings{dkc2020assessment,
  author = {Serkan Dıkıcı and Betül Aldemir Dikici and Shirin Issa Bhaloo and Mercedes Balcells and Elazer R. Edelman and Sheila MacNeil and Gwendolen C. Reilly and Colin Sherborne and Frederik Claeyssens},
  title = {{Assessment of the Angiogenic Potential of 2-Deoxy-D-Ribose Using a Novel in vitro 3D Dynamic Model in Comparison With Established in vitro Assays}},
  booktitle = {Frontiers in Bioengineering and Biotechnology},
  year = {2020},
  doi = {10.3389/fbioe.2019.00451},
}
Figure